stockportfolio.pro
Stocks / IRMD vs KMTS
IRMD vs KMTS
IRADIMED CORPORATION and Kestra Medical Technologies, Ltd. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| IRADIMED CORPORATION (IRMD) | Kestra Medical Technologies, Ltd. (KMTS) | |
|---|---|---|
| Market cap | $1.2B | $1.2B |
| Revenue (latest FY) | $83.81M | $59.81M |
| Net income (latest FY) | $22.48M | $-113.81M |
| Revenue growth (5y CAGR) | 21.5% | 180.0% |
| Net margin | 26.8% | -190.3% |
| Return on equity | 23.8% | -55.4% |
| P/E ratio | 52.3 | — |
| Dividend yield | 0.8% | — |
| Profitable years (of last 10) | 10 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open IRMD — free Open KMTS — freeFrequently asked questions
Which is bigger, IRMD or KMTS?
IRADIMED CORPORATION is larger by market capitalization — $1.2B versus $1.2B.
Which grows faster, IRMD or KMTS?
Over the last five fiscal years, Kestra Medical Technologies, Ltd. grew revenue faster — 180.0%/yr versus 21.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.